Received Sep 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Itching; General malaise, fever, general pain; General malaise, fever, general pain; General malaise, fever, general pain; Pain at injection site; redness at injection site; injection site warm to touch; Scab Injection site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included fibromyalgia (Fibromyalgia), blood pressure (Blood pressure) and diabetes (Diabetes). On 06-AUG-2025, the patient received Shingrix. On 06-AUG-2025, less than a day after receiving Shingrix, the patient experienced injection site pain (Verbatim: Pain at injection site), injection site erythema (Verbatim: redness at injection site), injection site warmth (Verbatim: injection site warm to touch), injection site scab (Verbatim: Scab Injection site), malaise (Verbatim: General malaise, fever, general pain), fever (Verbatim: General malaise, fever, general pain) and general body pain (Verbatim: General malaise, fever, general pain). On 16-AUG-2025, the patient experienced pruritus (Verbatim: Itching). In AUG-2025, the outcome of the injection site pain, injection site erythema, injection site warmth, malaise, fever and general body pain were resolved. The outcome of the injection site scab and pruritus were not resolved. It was unknown if the reporter considered the injection site pain, injection site erythema, injection site warmth, injection site scab, pruritus, malaise, fever and general body pain to be related to Shingrix. It was unknown if the company considered the injection site pain, injection site erythema, injection site warmth, injection site scab, pruritus, malaise, fever and general body pain to be related to Shingrix. Additional Information: GSK Receipt Date: 21-AUG-2025 The customer reported that after she received the Shingrix vaccine, she experienced pain at injection site for many days, redness, warm to touch, a scab developed at the injection site. Experienced itching, general malaise, fever, general pain.
Blood pressure (Blood pressure); Diabetes (Diabetes); Fibromyalgia (Fibromyalgia)